ANVISA registration 10259610205Valid until Jul 16, 2028

MYCOPLASMA

Name: MYCOPLASMA — ANVISA registration 10259610205
Creator: VIRCELL MICROBIOLOGISTS
Keywords: MYCOPLASMA, MYCOPLASMA, MYCOPLASMA PNEUMONIAE VIRCLIA IGM MONOTEST, 10259610205, Risk Class III, ANVISA registration

ANVISA Registration Number: 10259610205MEDIVAX INDÚSTRIA E COMÉRCIO LTDAVIRCELL MICROBIOLOGISTSRisk Class III

Verified

Device names

Technical name: MYCOPLASMA
Commercial name: MYCOPLASMA PNEUMONIAE VIRCLIA IGM MONOTEST
Risk class: Class III

Registration details

Registration Number: 10259610205
Process Number: 25351139034202339
CNPJ: 68814961000173

Company information

Registration Holder: MEDIVAX INDÚSTRIA E COMÉRCIO LTDA
Manufacturer: VIRCELL MICROBIOLOGISTS
Manufacturing Country: Spain

Dates and status

Publication Date: Mar 27, 2023
Validity: 16/07/2028
Last Updated: 08/18/2026 19:00:00

About this record

Access comprehensive regulatory information for MYCOPLASMA in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10259610205 and manufactured by VIRCELL MICROBIOLOGISTS. The registration is held by MEDIVAX INDÚSTRIA E COMÉRCIO LTDA with validity until Jul 16, 2028.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.